<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01757886</url>
  </required_header>
  <id_info>
    <org_study_id>ARTERIA-2012</org_study_id>
    <secondary_id>ARTERIA-2012</secondary_id>
    <nct_id>NCT01757886</nct_id>
  </id_info>
  <brief_title>inflAmmatory maRkers in Blood and Thrombus Aspirated From Patients With acutE myocaRdial Infarction With St-segment elevAtion</brief_title>
  <acronym>ARTERIA</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Canaria Rafael Clavijo para la Investigación Biomédica</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación Canaria Rafael Clavijo para la Investigación Biomédica</source>
  <brief_summary>
    <textblock>
      The prognostic value of inflammatory markers in acute coronary syndrome has been extensively
      demonstrated, however it is still unknown whether there is an association between circulating
      and local (thrombus) inflammatory molecules, and the subset of molecules that provide better
      prognostic information in patients with ST-elevation acute coronary syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>The primary objective of the study is to find out whether there is an association between certain inflammatory markers in blood and intracoronary thrombus and whether these markers are associated with the composite of all-cause mortality</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Patients Admitted With the Diagnosis of ST-elevation Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>ST-elevation acute coronary syndrome</arm_group_label>
    <description>ARTERY is a prospective, multicenter, which will include patients admitted with the diagnosis of ST-elevation acute coronary syndrome and thrombus aspiration is performed during primary angioplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biomarkers to analyze both intracoronary thrombi as blood</intervention_name>
    <arm_group_label>ST-elevation acute coronary syndrome</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pilot, prospective cohort, which included all patients admitted with a diagnosis of
        ST-elevation myocardial infarction and undergoing thrombus aspiration during a procedure
        effective emerging percutaneous coronary revascularization.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  They include patients of both sexes, without limits of age, with a diagnosis of STEMI
             within 12 hours after the beginning of symptoms. ST-elevation myocardial infarction
             was defined in the presence of symptoms consistent, persistent elevation (&gt; 20 min) ST
             segment ≥ 1 mm in at least two contiguous leads or in the presence of left bundle
             branch block presumably new onset and cardiac troponin I elevation

        Exclusion Criteria:

          -  Injury significant common core of left coronary artery (stenosis greater than or equal
             to 50% of the vessel lumen).

          -  Pre-Fibrinolysis percutaneous coronary intervention.

          -  Previous coronary bypass surgery.

          -  Thyrotoxicosis.

          -  Having an inflammatory systemic or local inflammatory process.

          -  Malignant neoplasm.

          -  Any disease that seriously compromise the prognosis and / or systemic inflammatory
             response generated.

          -  No thrombotic material obtained in the thrombus or insufficient for performing
             biochemical determinations.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alberto Dominguez-Rodriguez, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitario de Canarias</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alberto Dominguez-Rodriguez, MD, PhD</last_name>
    <phone>+34 922 679040</phone>
    <email>adrvdg@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario de Canarias</name>
      <address>
        <city>La Laguna</city>
        <state>Santa Cruz de Tenerife</state>
        <zip>E-38320</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Dominguez-Rodriguez, MD, PhD</last_name>
      <phone>+34 922 679040</phone>
      <email>adrvdg@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Alberto Dominguez-Rodriguez, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Canarias</name>
      <address>
        <city>La Laguna</city>
        <state>Santa Cruz de Tenerife</state>
        <zip>E-38320</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Dominguez-Rodriguez, MD, PhD</last_name>
      <phone>+34 922679040</phone>
      <email>adrvdg@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Canarias</name>
      <address>
        <city>La Laguna</city>
        <state>Tenerife</state>
        <zip>38320</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Dominguez-Rodriguez, MD, PhD</last_name>
      <phone>+34 922 679040</phone>
      <email>adrvdg@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 22, 2012</study_first_submitted>
  <study_first_submitted_qc>December 22, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2012</study_first_posted>
  <last_update_submitted>December 22, 2012</last_update_submitted>
  <last_update_submitted_qc>December 22, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 31, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundación Canaria Rafael Clavijo para la Investigación Biomédica</investigator_affiliation>
    <investigator_full_name>Enrique Quintero</investigator_full_name>
    <investigator_title>Alberto Dominguez Rodriguez</investigator_title>
  </responsible_party>
  <keyword>Myocardial infarction, Inflammation, Thrombus, Coronary angioplasty.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

